Tweet
<img alt="" height="1" width="1" />
Sarepta Therapeutics Announces Third Quarter 2013 Financial Results and ...
Wall Street Journal
CAMBRIDGE, MA--(Marketwired - Nov 12, 2013) - Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a developer of innovative RNA-based therapeutics, today reported financial results for the three and nine months ended September 30, 2013, and provided an ...
Sarepta tanks after FDA squelches hopes for early eteplirsen approvalFierceBiotech
Sarepta Serious Setback: FDA Says No Early Approval Filing for EteplirsenTheStreet.com
Sarepta Therapeutics Announces FDA Considers NDA Filing for Eteplirsen ...Benzinga
all 5 news articles »
More...